These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 3779659)

  • 1. Incorporation of iododeoxyuridine into DNA of granulocytes in patients.
    Belanger K; Klecker RW; Rowland J; Kinsella TJ; Collins JM
    Cancer Res; 1986 Dec; 46(12 Pt 1):6509-12. PubMed ID: 3779659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluorodeoxyuridine modulation of the incorporation of iododeoxyuridine into DNA of granulocytes: a phase I and clinical pharmacological study.
    Speth PA; Kinsella TJ; Belanger K; Klecker RW; Smith R; Rowland JB; Collins JM
    Cancer Res; 1988 May; 48(10):2933-7. PubMed ID: 2965970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo modulation of iododeoxyuridine metabolism and incorporation into cellular DNA by 5'-amino-5'-deoxythymidine in normal mouse tissues and two human colon cancer xenografts.
    Kinsella TJ; Glennon MC; Kunugi KA; Lindstrom MJ
    Clin Cancer Res; 1996 Jun; 2(6):981-9. PubMed ID: 9816259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leucovorin modulation of 5-iododeoxyuridine radiosensitization: a phase I study.
    McGinn CJ; Kunugi KA; Tutsch KD; Feierabend C; Alberti D; Lindstrom MJ; Wilding G; Arzoomanian RZ; Kinsella TJ
    Clin Cancer Res; 1996 Aug; 2(8):1299-305. PubMed ID: 9816300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measurement of thymidine replacement in patients with high grade gliomas, head and neck tumors, and high grade sarcomas after continuous intravenous infusions of 5-iododeoxyuridine.
    Cook JA; Glass J; Lebovics R; Bobo H; Pass H; DeLaney TF; Oldfield EH; Mitchell JB; Glatstein E; Goffman TE
    Cancer Res; 1992 Feb; 52(3):719-25. PubMed ID: 1732059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iododeoxyuridine (IdUrd) incorporation into DNA of human hematopoietic cells, normal liver and hepatic metastases in man: as a radiosensitizer and as a marker for cell kinetic studies.
    Speth PA; Kinsella TJ; Chang AE; Klecker RW; Belanger K; Smith R; Rowland J; Cupp JE; Collins JM
    Int J Radiat Oncol Biol Phys; 1989 May; 16(5):1247-50. PubMed ID: 2715075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of leucovorin on idoxuridine cytotoxicity and DNA incorporation.
    Greene RF; Collins JM
    Cancer Res; 1990 Oct; 50(20):6652-6. PubMed ID: 2208128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Iododeoxyuridine chemosensitization of cis-diamminedichloroplatinum(II) in human bladder cancer cells.
    Chi KH; Kunugi KA; Kinsella TJ
    Cancer Res; 1994 May; 54(10):2701-6. PubMed ID: 8168100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase I trial of intraperitoneal iododeoxyuridine with and without intravenous high-dose folinic acid in the treatment of advanced malignancies primarily confined to the peritoneal cavity: flow cytometric and pharmacokinetic analysis.
    Morgan RJ; Newman EM; Doroshow JH; McGonigle K; Margolin K; Raschko J; Chow W; Somlo G; Leong L; Tetef M; Shibata S; Hamasaki V; Carroll M; Vasilev S; Akman S; Coluzzi P; Wagman L; Longmate J; Paz B; Yen Y; Klevecz R
    Cancer Res; 1998 Jul; 58(13):2793-800. PubMed ID: 9661893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase I clinical and pharmacological study of iododeoxyuridine and bleomycin in patients with advanced cancer.
    Schilsky RL; Janisch L; Berezin F; Mick R; Vogelzang NJ; Ratain MJ
    Cancer Res; 1993 Mar; 53(6):1293-6. PubMed ID: 7680282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Technique for detection of DNA nucleobases by reversed-phase high-performance liquid chromatography optimized for quantitative determination of thymidine substitution by iododeoxyuridine.
    Belanger K; Collins JM; Klecker RW
    J Chromatogr; 1987 Jun; 417(1):57-63. PubMed ID: 3624403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of the metabolism and cytotoxicity of iododeoxyuridine by 5'-amino-5'-deoxythymidine.
    Fischer PH; Weddle MA; Mossie RD
    Mol Pharmacol; 1983 May; 23(3):709-16. PubMed ID: 6865913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Positive interactive radiosensitisation in vitro with the combination of two nucleoside analogues, (E)-2'-deoxy-2'-(fluoromethylene) cytidine and iododeoxyuridine.
    Coucke PA; Cottin E; Azria D; Martineau P; Adamer F; Decosterd LA; Buchegger F; Do HP
    Eur J Cancer; 2004 Jul; 40(10):1572-80. PubMed ID: 15196542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective radiosensitization of drug-resistant MutS homologue-2 (MSH2) mismatch repair-deficient cells by halogenated thymidine (dThd) analogues: Msh2 mediates dThd analogue DNA levels and the differential cytotoxicity and cell cycle effects of the dThd analogues and 6-thioguanine.
    Berry SE; Davis TW; Schupp JE; Hwang HS; de Wind N; Kinsella TJ
    Cancer Res; 2000 Oct; 60(20):5773-80. PubMed ID: 11059773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A method for determination of iododeoxyuridine substitution of thymidine using reversed-phase high-performance liquid chromatography.
    Yabuki H; Nath R
    Cell Prolif; 1991 Jan; 24(1):33-47. PubMed ID: 2009316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of base excision repair potentiates iododeoxyuridine-induced cytotoxicity and radiosensitization.
    Taverna P; Hwang HS; Schupp JE; Radivoyevitch T; Session NN; Reddy G; Zarling DA; Kinsella TJ
    Cancer Res; 2003 Feb; 63(4):838-46. PubMed ID: 12591735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective incorporation of iododeoxyuridine into DNA of hepatic metastases versus normal human liver.
    Speth PA; Kinsella TJ; Chang AE; Klecker RW; Belanger K; Collins JM
    Clin Pharmacol Ther; 1988 Oct; 44(4):369-75. PubMed ID: 3168389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved high-affinity monoclonal antibody to iododeoxyuridine.
    Vanderlaan M; Watkins B; Thomas C; Dolbeare F; Stanker L
    Cytometry; 1986 Nov; 7(6):499-507. PubMed ID: 3096672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ICI D1694 and idoxuridine: a synergistic antitumor combination.
    Pressacco J; Hedley DW; Erlichman C
    Cancer Res; 1994 Jul; 54(14):3772-8. PubMed ID: 8033097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preclinical evaluation of locoregional delivery of radiolabeled iododeoxyuridine and thymidylate synthase inhibitor in a hepatoma model.
    Chi KH; Wang HE; Chen FD; Chao Y; Liu RS; Chou SL; Wang YS; Yen SH
    J Nucl Med; 2001 Feb; 42(2):345-51. PubMed ID: 11216535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.